Krystal Biotech, Inc.
KRYS
$180.30
-$3.62-1.97%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.28% | 4.67% | 17.19% | 53.62% | 40.35% |
| Total Receivables | 149.16% | 944.42% | -- | -- | -- |
| Inventory | 279.50% | 252.05% | -- | -- | -- |
| Prepaid Expenses | 97.94% | 63.97% | 19.39% | 28.62% | 45.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.22% | 22.51% | 41.07% | 69.44% | 53.19% |
|
|
|||||
| Total Current Assets | 26.22% | 22.51% | 41.07% | 69.44% | 53.19% |
| Net Property, Plant & Equipment | -4.03% | -4.86% | -3.42% | -2.36% | -0.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.17% | -28.77% | -55.79% | -51.24% | -18.83% |
| Total Assets | 29.02% | 24.29% | 34.16% | 60.44% | 46.54% |
|
|
|||||
| Total Accounts Payable | 20.64% | 28.57% | 22.02% | 30.42% | 3.79% |
| Total Accrued Expenses | 190.82% | 269.70% | 225.85% | 124.44% | 57.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.44% | -13.92% | -10.99% | -7.92% | -5.57% |
| Total Finance Division Other Current Liabilities | 360.53% | 292.41% | 307.19% | 5.94% | -20.58% |
| Total Other Current Liabilities | 360.53% | 292.41% | 307.19% | 5.94% | -20.58% |
| Total Current Liabilities | 208.20% | 224.57% | 200.66% | 35.67% | 14.72% |
|
|
|||||
| Total Current Liabilities | 208.20% | 224.57% | 200.66% | 35.67% | 14.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.70% | -9.31% | -9.81% | -10.27% | -10.20% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 175.62% | 180.43% | 154.80% | 27.84% | 9.65% |
|
|
|||||
| Common Stock & APIC | 7.58% | 7.31% | 7.92% | 30.97% | 30.37% |
| Retained Earnings | 33.04% | 18.80% | 29.49% | 17.53% | 3.89% |
| Treasury Stock & Other | -129.78% | 495.81% | -168.64% | -94.16% | 187.64% |
| Total Common Equity | 21.54% | 17.18% | 28.45% | 63.26% | 49.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.54% | 17.18% | 28.45% | 63.26% | 49.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.54% | 17.18% | 28.45% | 63.26% | 49.10% |
|
|
|||||
